1. Home/
  2. Compounds/
  3. alisertib:navitoclax (2:1 mol/mol)

alisertib:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2alisertib:navitoclax (2:1 mol/mol)
PharmacoGx alisertib:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to alisertib:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ANXA5 CTRPv2 pan-cancer AAC -0.21 6e-06
mRNA MYOF CTRPv2 pan-cancer AAC -0.21 3e-07
mRNA EMC7 CTRPv2 pan-cancer AAC -0.21 1e-08
mRNA ATOX1 CTRPv2 pan-cancer AAC -0.19 9e-06
mRNA TPD52L2 CTRPv2 pan-cancer AAC -0.19 3e-07
mRNA NBPF14 CTRPv2 pan-cancer AAC -0.19 9e-08
mRNA FKBP10 CTRPv2 pan-cancer AAC -0.19 2e-06
mRNA UBTD1 CTRPv2 pan-cancer AAC -0.19 8e-06
mRNA AP003419.11 CTRPv2 pan-cancer AAC -0.19 2e-07
mRNA C11orf24 CTRPv2 pan-cancer AAC -0.18 5e-07
Download CSV